Company Profiles

driven by the PitchBook Platform

ACT Genomics

Description

Provider of cancer molecular information services. The company's implements next generation sequencing and multiplex molecular testing platform, coupling with bioinformatics tool, curated proprietary databases and data visualization technologies to address the key challenges in cancer treatments.

2014

Founded

PRIVATE

Status

51-200

Employees

Series B

Latest Deal Type

$12.5M

Latest Deal Amount

$20.5M

Total Amount Raised

Description

Provider of cancer molecular information services. The company's implements next generation sequencing and multiplex molecular testing platform, coupling with bioinformatics tool, curated proprietary databases and data visualization technologies to address the key challenges in cancer treatments.

Website:

www.actgenomics.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Outcome Management (Healthcare)

Other Industries

Other Healthcare

Primary Office

1F., Number 280 Xinhu 2nd Road, Neihu District Taipei City, 114Taiwan +886 (0)22 7953660
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore ACT Genomics's full profile, request a free trial.

ACT Genomics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

ACT Genomics Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
CDIB Capital InternationalVenture CapitalMinority000 0000000 0000
Eminent Venture CapitalVenture CapitalMinority000 0000000 0000
Hotung Investment HoldingsVenture CapitalMinority000 0000000 0000
Hua Nan Venture CapitalVenture CapitalMinority000 0000000 0000
President International DevelopmentCorporate Venture CapitalMinority000 0000000 0000
CDIB Capital International Venture Capital
Eminent Venture Capital Venture Capital
Hotung Investment Holdings Venture Capital
Hua Nan Venture Capital Venture Capital
President International Development Corporate Venture Capital

ACT Genomics Executive Team (3)

NameTitleBoard
Seat
Contact
Info
PJ HsuehChief Operating Officer
Hua-Chien Chen Ph.DCo-Founder & Chief Executive Officer
Shu-Jen Chen Ph.DCo-Founder & Chief Scientific Officer
PJ Hsueh Chief Operating Officer
Hua-Chien Chen Ph.D Co-Founder & Chief Executive Officer
Shu-Jen Chen Ph.D Co-Founder & Chief Scientific Officer
Request full access to PitchBook